Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 26 Genitourinary 12 Other hematologic neoplasm 6 Breast 6 Gynecologic 5 Thoracic 2 Plasma cell 2 Lymphoid 2 Head & Neck 2 Other 1 NET 1 Myeloid 1 Endocrine 1 CNS 1

Conditions

Neuroendocrine Tumors 531 Multiple Endocrine Neoplasia Type 1 187 Pituitary Neoplasms 186 Thyroid Cancer, Papillary 178 Pheochromocytoma 152 Carcinoma, Neuroendocrine 140 Thyroid Neoplasms 130 Neoplasms 107 Carcinoid Tumor 99 Paraganglioma 98 Adrenocortical Carcinoma 92 Thyroid Carcinoma, Anaplastic 82 Pancreatic Neoplasms 69 Neoplasm Metastasis 67 Insulinoma 61 Adrenal Gland Neoplasms 61 Gastro-enteropancreatic neuroendocrine tumor 58 Carcinoma, Medullary 58 Adenocarcinoma, Follicular 58 Carcinoma, Non-Small-Cell Lung 57 Breast Neoplasms 56 Adenoma, Islet Cell 56 Lung Neoplasms 50 Sarcoma 49 Colorectal Neoplasms 49 Carcinoma, Renal Cell 49 Melanoma 47 Small Cell Lung Carcinoma 45 Prostatic Neoplasms 44 Head and Neck Neoplasms 43

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Frailty × Endocrine × Clear all

NCT05554003 2024-11-18

MeTe

European Institute of Oncology

Phase 2 Recruiting

Frailty, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡